18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Glioblastoma Multiforme
Related studies linked through entity extraction aliases.
Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
- Status
- RECRUITING
- Phase
- NA
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
- Status
- COMPLETED
- Phase
- PHASE2
Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
- Status
- TERMINATED
- Phase
- PHASE1
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM
- Status
- COMPLETED
- Phase
- NA
Trial of AEO in New Glioblastoma (GBM)
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
- Status
- COMPLETED
- Phase
- NA
Evaluation of GLR2007 for Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
NG101m Adjuvant Therapy in Glioblastoma Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511
- Status
- TERMINATED
- Phase
- PHASE1
Expanded Access for KHK2455
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
Immunohistochemical Assessment of Programmed Death ligand1 and LC3B in GBM
- Status
- UNKNOWN
- Phase
- N/A
ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
- Status
- UNKNOWN
- Phase
- PHASE3
LAM561 With RT and TMZ for Adults With Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Repurposing Chlorpromazine in the Treatment of Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2